Exercício Físico Como Aliado Profilático Contra a COVID-19: Uma Hipótese Envolvendo o Receptor do Tipo Toll 7 (TLR-7)
Exercise as a prophylactic ally against covid-19: a hypothesis involving the Toll-Like Receptor 7
DOI:
10.46551/ruc.v25n1a8Palabras clave:
Exercício Físico, COVID-19, Imunidade Inata, SARS-CoV-2, TLR-7Resumen
Objetivo: Investigar a potencial relação entre o Receptor Toll-like 7 (TLR7) e o exercício físico na resposta imune contra a COVID-19. Método: Trata-se de uma revisão bibliográfica fundamentada por estudos originais em Língua Inglesa, indexados na base de dados PubMed e publicados entre 2006 e maio de 2022. Resultados: Evidências sugerem que o TLR7 é importante no processo imunológico inicial contra a COVID-19, pois é responsável no processo de ativação das células dendríticas plasmocitóides e produção de Interferons Tipo I (IFN-I), que estão relacionados à atenuação da gravidade da doença. Além disso, mutações de perda de função do TLR7 e a diminuição da resposta do IFN-I estão associadas ao agravamento da COVID-19. Embora nenhum estudo tenha avaliado diretamente a relação entre exercício físico e TLR7 em casos de COVID-19, evidências disponíveis sugerem que o exercício físico pode provocar alterações na expressão de TLR7, indicando um novo tema para investigação. Conclusões: Novos estudos são necessários para esclarecer os efeitos dos exercícios físicos sobre o TLR7 e seu potencial nas defesas antivirais contra a COVID-19, considerando especificidades como intensidade do exercício, modalidade do exercício, duração da sessão de treinamento ou programa de exercícios, população avaliada ou outras possíveis variáveis.
Descargas
Citas
Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK et al. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016;19(2):181-93. 10.1016/j.chom.2016.01.007.
Channappanavar R, Fehr AR, Zheng J, Wohlford-Lenane C, Abrahante JE, Mack M et al. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest. 2019;129(9):3625-3639. 10.1172/JCI126363.
Hatton CF, Botting RA, Dueñas ME, Haq IJ, Verdon B, Thompson BJ et al. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2. Nat Commun. 2021;12(1):7092. 10.1038/s41467-021-27318-0.
Kindler E, Thiel V. SARS-CoV and IFN: Too Little, Too Late. Cell Host Microbe.
;19(2):139–141. 10.1016/j.chom.2016.01.012.
Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in
COVID-19: An overview of the involvement of the chemokine/chemokine-receptor
system. Cytokine Growth Factor Rev. 2020;53:25-32. 10.1016/j.cytogfr.2020.05.003.
Salvi V, Nguyen HO, Sozio F, Schioppa T, Gaudenzi C, Laffranchi M et al. SARSCoV-2–associated ssRNAs activate inflammation and immunity via TLR7/8. JCI
Insight. 2021;6(18). 10.1172/jci.insight.150542.
Khanmohammadi S, Rezaei N. Role of Toll-like receptors in the pathogenesis of
COVID-19. J Med Virol. 2021;93(5):2735-2739. 10.1002/jmv.26826.
De Wit E, Van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent
insights into emerging coronaviruses. Nat Rev Microbiol, 2016;14:523-534.
https://doi.org/10.1038/nrmicro.2016.81.
Snell LM, Mcgaha TL, Brooks DG. Type I Interferon in Chronic Virus Infection and
Cancer. Trends Immunol. 2017;38(8):542-557. 10.1016/j.it.2017.05.005.
Nieman DC Henson DA; Austin MD, Brown VA. Immune response to a 30-minute
walk. Med Sci Sports Exerc, 2005;37(1):57-62. 10.1249/01.mss.0000149808.38194.21.
Nieman DC. COVID-19: A tocsin to our aging, unfit, corpulent, and immunodeficient
society. J Sport Health Sc. 2020;9(4):293-301. 10.1016/j.jshs.2020.05.001.
Laddu DR, Lavie CJ, Phillips SA, Arena R. Physical activity for immunity protection:
Inoculating populations with healthy living medicine in preparation for the next
pandemic. Prog Cardiovasc Dis. 2021;64:102-104. 10.1016/j.pcad.2020.04.006.
Jimeno-Almazán A, Pallarés JG, Buendía-romero Á, Martínez-Cava A, Franco-López
F, Martínez BJ Sánchez-Alcaraz et al. Post-COVID-19 Syndrome and the Potential
Benefits of Exercise. Int J Environ Res Public Health. 2021;18(10):5329.
3390/ijerph18105329.
Jimeno-Almazán A, Martínez-Cava A, Buendía-Romero Á, Franco-López F, SánchezAgar JÁ, Sánchez-Alcaraz BJ et al. Relationship between the severity of persistent
symptoms, physical fitness, and cardiopulmonary function in post-COVID-19
condition. A population-based analysis. Intern Emerg Med. 2022;1-10.
1007/s11739-022-03039-0.
Baker FL, Smith KA, Zuniga TM, Batatinha H; Niemiro GM, Pedlar CR et al. Acute
exercise increases immune responses to SARS CoV-2 in a previously infected man.
Brain Behav Immun Health. 2021;18. 10.1016/j.bbih.2021.100343.
Rodríguez-Blanco C; Bernal-Utrera C, Anarte-Lazo E, Saavedra-Hernandez M, De-LaBarrera-Aranda E, Serrera-Figallo MA et al. Breathing exercises versus strength
exercises through telerehabilitation in coronavirus disease 2019 patients in the acute
phase: A randomized controlled trial. Clin Rehabil. 2022;36(4):486-497.
1177/02692155211061221.
Halabchi F, Selk-Ghaffari M, Tazesh B, Mahdaviani B. The effect of exercise
rehabilitation on COVID-19 outcomes: a systematic review of observational and
intervention studies. Sport Sci Health. 2022;1-19. 10.1007/s11332-022-00966-5.
Martin SA, Pence BD, Woods JA. Exercise and Respiratory Tract Viral Infections.
Exerc Sport Sci Rev. 2009;37(4):157–164. 10.1097/JES.0b013e3181b7b57b.
Woods JA, Hutchinson NT, Powers SK, Roberts WO, Gomez-Cabreza MC, Radak Z et
al. The COVID-19 pandemic and physical activity. Sports Medicine and Health
Science. 2020;2(2):55-64. https://doi.org/10.1016/j.smhs.2020.05.006.
Nieman DC. Exercise Is Medicine for Immune Function: Implication for COVID-19.
Curr Sports Med Rep. 2021;20(8):395-401. 10.1249/JSR.0000000000000867.
Nickel T, Hanssen H, Emslander I, Drexel V, Hertel G, Schmidt-Trucksass A et al.
Immunomodulatory Effects of Aerobic Training in Obesity. Mediators of Inflamm,
;1–10. 10.1155/2011/308965.
Nickel T, Emslander I, Sisic Z, David R, Schmaderer C, Marx N et al. Modulation of
dendritic cells and toll-like receptors by marathon running. Eur J Appl Physiol,
;112(5):1699–1708. 10.1007/s00421-011-2140-8.
Zheng Q, Cui G, Chen J; Gao H, Wei Y, Uede T et al. Regular exercise enhances the
immune response against microbial antigens through up-regulation of toll-like receptor
signaling pathways. Cell Physiol Biochem. 2015;37(2):735-46. 10.1159/000430391.
Lackermair K, Scherr J, Waidhauser G, Methe H, Hoster E, Nieman DC et al. Influence
of polyphenol-rich diet on exercise-induced immunomodulation in male endurance
athletes. Appl Physiol Nutr Metab, 2017;42(10):1023–1030. 10.1139/apnm-2017-0063.
Perkins RK, Lavin KM, Raue U, Jemiolo B, Trappe SW, Trappe TA. Effects of aging
and lifelong aerobic exercise on expression of innate immune components in human
skeletal muscle. J Appl Physiol (1985). 2020;129(6):1483-1492.
1152/japplphysiol.00615.2020.
Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol.
;5:461. 10.3389/fimmu.2014.00461.
Cervantes-Barragan L, Zust R, Weber F, Spiegel M, Lang KS, Akira S et al. Control of
coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon.
Blood. 2006;109(3):1131–1137. 10.1182/blood-2006-05-023770.
Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID19 and potential
vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy
Immunol. 2020;38:1-9. 10.12932/AP-200220-0772.
Moreno-Eutimio MA, López-Macías C, Pastelin-Palacios R. Bioinformatic analysis and
identification of single-stranded RNA sequences recognized by TLR7/8 in the SARSCoV-2, SARS-CoV, and MERS-CoV genomes. Microbes Infect. 2020;22(4-5):226-
10.1016/j.micinf.2020.04.009.
Shaath H, Vishnubalaji R, Elkord E, Alajez NM. Single-Cell Transcriptome Analysis
Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis
of Severe COVID-19. Cells. 2020;9(11):2374. 10.3390/cells9112374.
Faghy MA; Arena R, Stoner L, Haraf RH, Josephson R, Hills PA et al. The need for
exercise sciences and an integrated response to COVID-19: A position statement from
the international HL-PIVOT network. Prog Cardiovasc Dis. 2022;67:2-10.
1016/j.pcad.2021.01.004.
Severa M, Diotti RA, Etna MP, Rizzo F, Fiore S, Ricci D et al. Differential plasmacytoid
dendritic cell phenotype and type I Interferon response in asymptomatic and severe
COVID-19 infection. PLoS Pathog. 2021;17(9). 10.1371/journal.ppat.1009878.
Van Der Sluis RM; Cham LB, Gris-Oliver A, Gammelgaard KR, Pedernsen JG, Idorn
M et al. TLR2 and TLR7 mediate distinct immunopathological and antiviral
plasmacytoid dendritic cell responses to SARS-CoV-2 infection. EMBO J. 2022;41(10).
15252/embj.2021109622.
Bortolotti D, Gentili V, Rizzo S, Schiuma G, Beltrami S, Strazzabosco G et al. TLR3
and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection. Microorganism.
;9(9):1820. 10.3390/microorganisms9091820.
Van Der Made CI, Simons A, Schuurs-Hoeijmakers J, Van Den Heuvel G; Mantere T,
Kersten S et al. Presence of genetic variants among young men with severe COVID-19.
JAMA. 2020;324(7):663-673. 10.1001/jama.2020.13719.
Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Renkilaraj MRLM et
al. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with lifethreatening COVID-19. Sci Immunol. 2021;6(62). 10.1126/sciimmunol.abl4348.
Fallerini C, Daga S, Mantovani S, Benetti E, Picchiotti N, Francisci D et al. Association
of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males:
findings from a nested case-control study. Elife. 2021;10. 10.7554/eLife.67569.
Solanich X, Vargas-Parra G, Van Der Made CI, Simons A, Schuurs-Hoeijmakers J,
Antolí A et al. Genetic screening for TLR7 variants in young and previously healthy
men with severe COVID-19. Front Immunol. 2021;12.
https://doi.org/10.3389/fimmu.2021.719115.
Minashkin MM, Grigortsevich N, Kamaeva AS, Barzasona VV, Traspov AA, Godkov
MA et al. The Role of Genetic Factors in the Development of Acute Respiratory Viral
Infection COVID-19: Predicting Severe Course and Outcomes. Biomedicines.
;10(3):549. 10.3390/biomedicines10030549.
Alseoudy MM, Elgamal M, Abdelghany DA, Borg AM, El-Mesery A, Elzeiny D et al.
Prognostic impact of toll-like receptors gene polymorphism on outcome of COVID-19
pneumonia: A case-control study. Clin Immunol. 2022;235.
1016/j.clim.2022.108929.
El-Hefnawy S, Eid HA, Mostafa RF, Soliman S, Omar TA, Azmy RM. COVID-19
susceptibility, severity, clinical outcome and Toll-like receptor (7) mRNA expression
driven by TLR7 gene polymorphism (rs3853839) in middle-aged individuals without
previous comorbidities. Gene rep. 2022;27. 10.1016/j.genrep.2022.101612.
Mantovani S, Daga S, Fallerini C, Baldassarri M, Benetti E, Picchiotti N et al. Rare
variants in Toll-like receptor 7 results in functional impairment and downregulation of
cytokine-mediated signaling in COVID-19 patients. Genes Immun. 2022;23(1):51-56.
1038/s41435-021-00157-1.
Abolhassani H, Vosughimotlagh A, Asano T, Landegren N, Boisson B, Delavari S et
al. X-Linked TLR7 deficiency underlies critical covid-19 pneumonia in a male patient
with ataxia-telangiectasia. J Clin Immunol. 2022;42(1):1-9. 10.1007/s10875-021-
-y.
Pessoa NL, Diniz LMO, Andrade AS, Kroon EG, Bentes AA, Campos MA. Children
with sickle cell disease and severe COVID-19 presenting single nucleotide
polymorphisms in innate immune response genes - a case report. EJHaem.
a;3(1):199-202. 10.1002/jha2.325.
Pessoa NL, Bentes AA, Carvalho AL, Silva TBS, Alves PA, Reis EVS et al. Case report:
hepatitis in a child infected with SARS-CoV-2 presenting toll-like receptor 7 Gln11Leu
single nucleotide polymorphism. Virol J. 2021b;18(1):180. 10.1186/s12985-021-
-3.
Yano H, Ushida M, Nakai R, Ishida K, Kato Y, Kawanishi N et al. Exhaustive exercise
reduces TNF-α and IFN-α production in response to R-848 via toll-like receptor 7 in
mice. Eur J Appl Physiol. 2010;110:797–803. https://doi.org/10.1007/s00421-010-
-1.
Campbell JP, Turner JE. Debunking the Myth of Exercise-Induced Immune Suppression: Redefining the Impact of Exercise on Immunological Health Across the Lifespan. Front Immunol. 2018;9:648. 10.3389/fimmu.2018.00648.
Nieman DC, Wentz LM. The compelling link between physical activity and the body's defense system. J Sport Health Sci. 2019;8(3):201-217. 10.1016/j.jshs.2018.09.009.
